André Boulet
Gründer bei DEVONIAN HEALTH GROUP INC.
Vermögen: 3 Mio $ am 31.05.2024
Profil
André P.
Boulet is the founder.
He founded Devonian Health Group, Inc. in 2015 and currently holds the title of Chairman & Chief Operating Officer.
He is also currently working as a Director at Montreal Heart Institutes Technology Transfer Corp., The American Botanical Drug Association, Inc., and Folia Biotech, Inc. In the past, he worked as a Director at Bioxel Pharma, Inc. from 2000 to 2008 and as a Partner at Biocapital Investments Ltd from 1996 to 2002.
He also held positions as a Faculty Member at the American Society of Hypertension and as VP-Scientific Affairs & Managing Partner at Sipar SA (France).
Dr. Boulet served as the President & Chief Operating Officer at PurGenesis Technologies, Inc. from 2013 to 2016.
He completed his undergraduate degree at the University of Quebec in 1981 and obtained his graduate and doctorate degrees from Université Laval in 1985 and 1988 respectively.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DEVONIAN HEALTH GROUP, INC.
13,69% | 09.01.2024 | 20 083 189 ( 13,69% ) | 3 Mio $ | 31.05.2024 |
Aktive Positionen von André Boulet
| Unternehmen | Position | Beginn |
|---|---|---|
| DEVONIAN HEALTH GROUP INC. | Gründer | 27.03.2015 |
| Montreal Heart Institutes Technology Transfer Corp. | Direktor/Vorstandsmitglied | 05.03.2010 |
The American Botanical Drug Association, Inc.
 The American Botanical Drug Association, Inc. Miscellaneous Commercial ServicesCommercial Services The American Botanical Drug Association, Inc. operates as botanical drug industry. The firm serves as a platform for dialogues among government agencies, private enteritis, and academics, by means of conferences, meetings, and tours. It offers public awareness of botanical drugs, facilitate government healthcare policy formation and fund innovative scientific research. The company is headquartered in Lake Hiawatha, NJ. | Direktor/Vorstandsmitglied | 05.03.2010 |
Folia Biotech, Inc.
 Folia Biotech, Inc. Drugstore ChainsRetail Trade FOLIA BIOTECH, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on exploiting its proprietary immuno-therapeutic platform to bring to market efficacious therapeutic products that fulfill large unmet needs principally in oncology and certain infectious diseases. The company was founded by Denis Leclerc in 2006 and is headquartered in Quebec, Canada. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von André Boulet
| Unternehmen | Position | Ende |
|---|---|---|
PurGenesis Technologies, Inc.
 PurGenesis Technologies, Inc. Pharmaceuticals: MajorHealth Technology PurGenesis Technologies, Inc. develops and manufactures patented ingredients from natural sources. It offers anti-aging and sun care products for the cosmeceutical market. The firm develops prescription botanically-sourced therapeutics that address areas of unmet medical need. The company was founded by Purcell Marc in 1999 and is headquartered in Montmagny, Canada. | Präsident | 01.11.2016 |
Bioxel Pharma, Inc.
 Bioxel Pharma, Inc. BiotechnologyHealth Technology Bioxel Pharma, Inc. develops pharmaceutical products used in the treatment of cancer, multiple sclerosis and Alzheimers. The company is engaged in the development, production and distribution of therapeutically active taxanes isolated from the Canadian yew. Bioxel Pharma was founded on July 13, 1995 and is headquartered in Quebec, Canada. | Direktor/Vorstandsmitglied | 01.12.2008 |
Biocapital Investments Ltd
 Biocapital Investments Ltd Investment Banks/BrokersFinance Biocapital Investments Ltd is a company based in Montréal, Canada. | Corporate Officer/Principal | 01.01.2002 |
| American Society of Hypertension | Corporate Officer/Principal | - |
Sipar SA (France)
 Sipar SA (France) Other Consumer SpecialtiesConsumer Durables Sipar SA is a private company based in Mende, France. The French company manufactures jewelry and costume jewelry products. | Corporate Officer/Principal | - |
Ausbildung von André Boulet
| University of Quebec | Undergraduate Degree |
| Université Laval | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DEVONIAN HEALTH GROUP INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Bioxel Pharma, Inc.
Bioxel Pharma, Inc. BiotechnologyHealth Technology Bioxel Pharma, Inc. develops pharmaceutical products used in the treatment of cancer, multiple sclerosis and Alzheimers. The company is engaged in the development, production and distribution of therapeutically active taxanes isolated from the Canadian yew. Bioxel Pharma was founded on July 13, 1995 and is headquartered in Quebec, Canada. | Health Technology |
PurGenesis Technologies, Inc.
PurGenesis Technologies, Inc. Pharmaceuticals: MajorHealth Technology PurGenesis Technologies, Inc. develops and manufactures patented ingredients from natural sources. It offers anti-aging and sun care products for the cosmeceutical market. The firm develops prescription botanically-sourced therapeutics that address areas of unmet medical need. The company was founded by Purcell Marc in 1999 and is headquartered in Montmagny, Canada. | Health Technology |
| Montreal Heart Institutes Technology Transfer Corp. | |
The American Botanical Drug Association, Inc.
The American Botanical Drug Association, Inc. Miscellaneous Commercial ServicesCommercial Services The American Botanical Drug Association, Inc. operates as botanical drug industry. The firm serves as a platform for dialogues among government agencies, private enteritis, and academics, by means of conferences, meetings, and tours. It offers public awareness of botanical drugs, facilitate government healthcare policy formation and fund innovative scientific research. The company is headquartered in Lake Hiawatha, NJ. | Commercial Services |
Folia Biotech, Inc.
Folia Biotech, Inc. Drugstore ChainsRetail Trade FOLIA BIOTECH, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on exploiting its proprietary immuno-therapeutic platform to bring to market efficacious therapeutic products that fulfill large unmet needs principally in oncology and certain infectious diseases. The company was founded by Denis Leclerc in 2006 and is headquartered in Quebec, Canada. | Retail Trade |
Sipar SA (France)
Sipar SA (France) Other Consumer SpecialtiesConsumer Durables Sipar SA is a private company based in Mende, France. The French company manufactures jewelry and costume jewelry products. | Consumer Durables |
Biocapital Investments Ltd
Biocapital Investments Ltd Investment Banks/BrokersFinance Biocapital Investments Ltd is a company based in Montréal, Canada. | Finance |
| American Society of Hypertension |
